Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when CRIS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company received formal delisting notice from Nasdaq due to sustained bid price violation below $1.00 per share for 30 consecutive business days.
Curis receives Nasdaq delisting notice; stock to be suspended May 6 unless appeal succeeds
Filed May 1, 2026 · Period ending April 27, 2026 · ~1 min read
Key Changes
-
high
Nasdaq notified Curis on April 27 that its stock will be delisted and suspended from trading on May 6, 2026, because the bid price stayed below $1.00 for 30 consecutive business days, violating exchange rules.
Item 3.01 verify on EDGAR → -
high
Company is already under one-year Discretionary Panel Monitor status (since Feb 2026), meaning this new violation triggers immediate delisting without the usual grace periods or compliance plans that other companies typically receive.
Item 3.01 verify on EDGAR → -
high
Curis plans to appeal by the May 4 deadline, which would temporarily halt delisting, but management warns there's no guarantee the appeal will succeed or that Nasdaq listing will be maintained.
Item 3.01 verify on EDGAR →
Summary
Curis disclosed it received a delisting determination from Nasdaq on April 27, 2026, after its stock bid price remained below $1.00 for 30 consecutive trading days. The company's shares are scheduled to be suspended from trading on May 6, 2026, unless it successfully appeals.
This situation is particularly serious because Curis has been under a Discretionary Panel Monitor since February 2026, which strips away the normal compliance grace periods that companies typically receive for listing violations. For retail investors, this means immediate liquidity risk.
If delisted, the stock would likely move to over-the-counter markets where trading is less liquid, spreads are wider, and institutional ownership often evaporates. The company plans to appeal by the May 4 deadline, which would pause the delisting temporarily, but management explicitly states there's no guarantee of success. Investors should watch for the appeal outcome announcement and monitor whether the company can execute a reverse stock split or other measures to regain compliance. The next critical date is May 4 (appeal deadline), followed by May 6 (scheduled suspension date).
Section-by-Section Diff
Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Curis received Nasdaq delisting notice due to 30-day bid price below $1.00; will appeal but delisting scheduled May 6, 2026.
Added in current filing · verify on EDGAR →
On April 27, 2026, the Company received a Delist Determination Letter from the Staff notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a) (2) (the “Bid Price Rule”), and the Company’s securities will be scheduled for delisting from the Nasdaq Capital Market and suspended at the opening of trading on May 6, 2026 unless the Company timely appeals the Staff’s delisting determination by requesting a hearing before the Panel by May 4, 2026.
Curis received a delisting notice from Nasdaq on April 27, 2026 because its stock bid price stayed below $1.00 per share for 30 consecutive business days, violating Nasdaq's minimum bid price rule. Trading will be suspended on May 6, 2026 unless the company appeals by May 4, 2026. The company intends to appeal, but there is no guarantee the appeal will succeed.
Added in current filing · verify on EDGAR →
As previously disclosed, on February 3, 2026, Curis, Inc. (the “Company”) became subject to a Discretionary Panel Monitor for a period of one-year pursuant to Listing Rule 5815(d) (4) (A). If, within the one-year monitoring period, the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) finds the Company again out of compliance with any of Nasdaq’s Listing Rules, notwithstanding Rule 5810(c) (2), the Company will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency, and the Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, nor will the Company be afforded an applicable cure or compliance period pursuant to Rule 5810(c) (3).
The company was already under a one-year Discretionary Panel Monitor starting February 3, 2026, which means any new listing violation triggers immediate delisting proceedings without the usual cure periods or compliance plans. This monitoring status made the current bid price violation more severe, as the company cannot negotiate additional time to fix the problem through normal channels.
Added in current filing · verify on EDGAR →
The Company intends to make a timely request for a new hearing with the initial Panel or a newly convened Panel if the initial Panel is unavailable, which will stay any further delisting actions. However, there can be no assurance that such appeal will be successful or that the Company will remain listed on Nasdaq.
Curis plans to request a hearing before a Nasdaq Hearings Panel by the May 4, 2026 deadline, which will temporarily halt the delisting process. However, management explicitly states there is no guarantee the appeal will succeed or that the company will maintain its Nasdaq listing, indicating significant uncertainty about the outcome.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify